Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 May;240(1):197-204.
doi: 10.1016/j.atherosclerosis.2015.03.019. Epub 2015 Mar 16.

High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis

Fabrizio D'Ascenzo  1 , Enrico Cerrato  2 , Andrea Calcagno  3 , Walter Grossomarra  4 , Flavia Ballocca  4 , Pierluigi Omedè  4 , Antonio Montefusco  4 , Simona Veglia  5 , Umberto Barbero  4 , Sebastiano Gili  4 , Margherita Cannillo  4 , Martina Pianelli  4 , Elisa Mistretta  4 , Alessio Raviola  4 , Davide Salera  4 , Domenica Garabello  5 , Massimo Mancone  6 , Vicente Estrada  7 , Javier Escaned  8 , Daniela De Marie  9 , Antonio Abbate  10 , Stefano Bonora  3 , Giuseppe Biondi Zoccai  11 , Claudio Moretti  2 , Fiorenzo Gaita  4
Affiliations
Free article
Review

High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis

Fabrizio D'Ascenzo et al. Atherosclerosis. 2015 May.
Free article

Abstract

Introduction: Asymptomatic patients with human immunodeficiency virus (HIV) infection are at increased risk of vascular disease. Whether asymptomatic HIV patients have increased prevalence or structural differences in coronary artery plaques is not clear.

Methods: Pubmed, Cochrane and Google Scholar were searched for articles evaluating asymptomatic HIV patients evaluated with coronary computed tomography. The prevalence of coronary stenosis (defined as >30% and >50%), of calcified coronary plaques (CCP) viewed as more 'stable' plaques, and of non-calcified coronary plaques (NCP) viewed as more 'vulnerable' plaques were the end points of interest.

Results: 9 studies with 1229 HIV patients and 1029 controls were included. No significant differences were detected about baseline cardiovascular risk profile. The prevalence of significant coronary stenosis>30% or >50% did not differ between HIV+ and HIV- patients (42% [37-44] and 46% [35-52] with an Odds Ratio [OR] of 1.38 [0.86-2.20] for >30% stenosis) and (15% [9-21] and 14% [7-22] with an OR of 1.11 [0.81-1.52]), respectively. The prevalence of calcified coronary plaques (CCP) (31% [24-32] and 21% [14-30] with an OR of 1.17 [0.63-2.16]) also did not differ among HIV+ and HIV- patients. On the contrary rates of NCP were >3-fold higher in HIV-positive patients [58% (48-60) and 17% (14-27) with an OR of 3.26 (1-30-8.18)], with an inverse relationship with CD4 cell count at meta-regression (Beta -0.20 [-0.35-0.18], p 0.04).

Conclusion: Asymptomatic HIV patients present a similar burden of coronary stenosis and calcified coronary artery plaques but significantly higher rates of non-calcific coronary plaques at computed tomography. The association between HIV infection, reduced CD4 cell counts and higher prevalence on non-calcific coronary artery plaques may shed light into the pathogenesis in HIV-associated coronary artery disease, stressing the importance of primary prevention in this population.

Keywords: CCT; HAART; HIV; Non calcific plaques.

PubMed Disclaimer

Comment in

MeSH terms